Amy McBride Wendell, Director at Axogen, Inc. (AXGN), sold 82,368 shares at $29.31 ($2.4M) on 2025-12-16, disclosed to the SEC on 2025-12-17.
Open-market sale of $2.4M AXGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.31 | 5,000 | $147K | 6.1% |
| 2 | $29.31 | 18,248 | $535K | 22.2% |
| 3 | $29.31 | 18,248 | $535K | 22.2% |
| 4 | $29.31 | 20,436 | $599K | 24.8% |
| 5 | $29.31 | 20,436 | $599K | 24.8% |
| Total | $29.31 avg | 82,368 |
| $2.4M |
| 100% |
| Filing → |
| SOLV | BUY | 2026-03-11 | $100K | — | Filing → |
| AXGN | SELL | 2025-06-11 | $43K | — | Filing → |
| AXGN | SELL | 2025-03-05 | $100K | — | Filing → |